galactosyl-(1-3)galactose has been researched along with Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, Y; Iwamori, M; Kashiwagi, M; Nagai, Y; Toda, G | 1 |
1 other study(ies) available for galactosyl-(1-3)galactose and Liver Diseases
| Article | Year |
|---|---|
Significant increase in the antibody to Gal alpha 1-3Gal structure in sera of patients with hepatocellular carcinoma after transcatheter arterial embolization.
Topics: Animals; Antibodies, Neoplasm; Antigens, Neoplasm; Carcinoma, Hepatocellular; Chronic Disease; Disaccharides; Embolization, Therapeutic; Enzyme-Linked Immunosorbent Assay; Glycosphingolipids; Humans; Immunoglobulin G; Liver Diseases; Liver Neoplasms; Rabbits | 1989 |